Asthma

The study found that PARTICS, in addition to the usual care these patients received, reduced severe asthma exacerbations by 15.4% (p50.048) which corresponded to a reduction of 13 exacerbations/100 patient-years.

Patients with allergic asthma could often have no clinical history of atopic dermatitis.

Knowledge on distinguishing moderate and severe eczema increased the most after the video training.

Dr. McKeon speaks of how patients can be more involved with managing their asthma and allergies by avoiding exposures in their own homes.

Though telemedicine has improved upon school-based asthma programs across the country, Dr. Phipatanakul notes that the adoption of these programs can be difficult to implement.

Dr. Trivedi speaks of a new text-based program that helps provide asthma care to children from communities of color, as well as how COVID-19 affected school-based asthma programs.

Dr. Zein speaks of the relationship between eosinophil count and COVID-19 illness and mortality, especially as it related to inhaled corticosteroid use.

The American College of Allergy, Asthma, and Immunology identify key practices for addressing allergies during the COVID-19 pandemic.

Patients with asthma and bronchiectasis were more likely to have chronic rhinosinusitis than patients without bronchiectasis, according to investigators.

Previous contrasting studies found that omalizumab was less effective in reducing exacerbations in obese patients.

New data from the NAVIGATOR study found that tezepelumab was associated with fewer asthma exacerbations throughout all seasons of the year compared to placebo.

Dr. Shrine and colleagues conducted the largest genome-wide association study of coexisting asthma and COPD to date in a 2-stage design incorporating a total of 13 studies.

A better understanding of this connection could yield preventative treatments.

Patients with asthma were at increased risk of hospitalization and ICU admission or death, prompting investigators to suggest these patients be considered a priority group for booster COVID-19 vaccines.

Patients with severe eosinophilic asthma who stopped treatment also experienced reduced asthma control and shorter times for clinically significant exacerbations.

More than 70% of parents of children with asthma said they in favor of the influenza vaccine during the COVID-19 pandemic.

Investigators concluded that long-term data are needed regarding surgery, but confirmed it to be more efficacious than medical therapy alone.

Allergists discuss the differing opinions of allergies and optimizing patient care during the COVID-19 pandemic.

New data from the Liberty Asthma VOYAGE study saw fewer asthma exacerbations and improved lung function in this patient population.

Investigators detail the clinical criteria of the condition and speak to the safety of the COVID-19 vaccine for this patient population.

Investigators suggested that peer-led asthma program implemented in venues such as schools, houses of worship, or clinics can improve access to asthma education.

Authors suggest children with uncontrolled asthma should be considered for priority for COVID-19 vaccination.

Despite some overlapping risk factors, investigators noted that no common risk factors were identified in all 3 conditions.

Investigators added that this risk might possibly be through intrauterine effects, while associations with wheezing might be confounded by familial clustering factors.

Further research is needed to devise strategies for the prevention and treatment of asthma attacks.

Despite this, asthma severity was not associated with higher risk of COVID-19.

To date, dupilumab is the only medicine to show clinically meaningful phase 3 results in this patient population, with regulatory fillings planned for 2022.

The indication makes 6 to 11-year-old children with eosinophilic biomarkers or corticosteroid dependency eligible for the biologic add-on therapy.

New data reveals that the pandemic led to significantly less medicines being taken by pediatric patients during the first lockdown in Finland.

There were no episode of gastrointestinal bleeding, transfusion of packed red blood cells, or octreotide infusions observed.